Angiogenic activity and VEGF level in sera of diabetic patients with non-proliferative retinopathy;Aktywność angiogenna i stȩżenie VEGF w surowicach chorych na cukrzycȩ powikłana̧ retinopatia̧ prosta̧

Klinika Oczna

Volumn 106, Issue 3 SUPPL., 2004, Pages 421-423

  Skopiński, Piotr ^a,b,d   Duda Król, Barbara ^a   Lipińska, Anna ^a   Sommer, Ewa ^c   Chorostowska Wynimko, Joanna ^c   Demkow, Urszula ^c   Szaflik, Jerzy ^a   Skopińska Rózewska, Ewa ^c   Struzik, Ewa ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Centrum Biostruktury

^c INSTYTUT GRU LICY I CHORÓB P UC   (Poland)

^d MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Angiogenesis; Diabetes type 1 (DM1) and type 2 (DM2); Non proliferative retinopathy; VEGF

Indexed keywords

VASCULOTROPIN A;

ADULT; AGED; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; DIABETIC RETINOPATHY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; REFERENCE VALUE; RETINA NEOVASCULARIZATION; SKIN; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; REFERENCE VALUES; RETINAL NEOVASCULARIZATION; SKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 15744386378     PISSN: 00232157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Das A., McGuire P. G.: Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition. Prog. Retin. Eye Res., 2003, 22, 721-748.
2. Aiello L. P., Wong J. S.: Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int. Suppl., 2000, 77, S113-S119.
3. Funatsu H., Yamashita H., Noma H., Shimizu E., Yamashita T., Hori S.: Stimulation and inhibition of angiogenesis in diabetic retinopathy. Jpn. J. Ophthalmol., 2001, 45, 577-584.
4. Ozaki H., Seo M. S., Ozaki K., Yamada H., Yamada E., Okamoto N., Hofmann F., Wood J. M., Campochiaro P. A.: Blockade of vascular endothelial growth factor receptor signaling is sufficient to copmpletly prevent retinal neovascularisation. Am. J. Pathol., 2000, 156, 697-707.
5. Rogala E., Skopińska-Różewska E., Załȩ ska J., Borowska A., Demkow U., Skopiński P., Dziedzic D., Langford R., Orłowski T.: Ocena aktywności enzymu konwertuja̧cego angiotensynȩ (ACE) oraz aktywność angiogenna surowic chorych na niedrobnokomórkowego raka płuca. Onkol. Pol., 2002, 5, 139-142.
6. Barcz E., Skopińska-Różewska E., Kamiński P., Demkow U., Bobrowska K., Marianowski L.: Angiogenic ativity and IL-8 concentrations in peritoneal fluid and sera in endometriosis. Int. J. Gynecol. Obstetrics., 2002, 79, 229-235.
7. Sidky Y. A., Auerbach R.: Lymphocyte-induced angiogenesis: A quantitative and sensitive assay of graft-vs-host reaction. J. Exp. Med., 1975, 141, 1084-1100.
8. Skopiński P., Sommer E., Kwiek S., Hevelke A., Rogala E., Skopińska-Różewska E.: Angiotensin - Converting Enzyme (ACE) activity and angiomodulatory effects of diabetic retinopathy patients sera. Int. J. Clin. Pharm. Res., 2001, XXI, 27-32.